{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Iodine_I_131_Monoclonal_Antibody_81C6",
  "nciThesaurus": {
    "casRegistry": "1000874-23-6",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A radioimmunoconjugate consisting of 81C6, a murine IgG2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131), with radioimaging and radioimmunotherapeutic activities. Using monoclonal antibody 81C6 as a carrier for I-131 results in the targeted imaging and/or destruction of cells expressing tenascin. Tenascin is an extracellular matrix protein which is overexpressed in gliomas and other cancers.",
    "fdaUniiCode": "D4E1UP3RMV",
    "identifier": "C2488",
    "preferredName": "Iodine I 131 Monoclonal Antibody 81C6",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129819",
      "C1511"
    ],
    "synonyms": [
      "81C6-I-131",
      "I 131 Monoclonal Antibody 81C6",
      "IODINE I-131 MONOCLONAL ANTIBODY 81C6",
      "Iodine I 131 Monoclonal Antibody 81C6",
      "Neuradiab",
      "iodine I 131 MOAB 81C6"
    ]
  }
}